miR-375 Promotes Pancreatic Differentiation In Vitro by Affecting Different Target Genes at Different Stages
Human embryonic stem cells (hESCs) possess the ability to differentiate into insulin-producing cells (IPCs), which can be used to treat type I diabetes. miR-375 is an essential transcriptional regulator in the development and maturation of the pancreas. In this study, we optimized a protocol to diff...
Main Authors: | Zhenyu Lu, Jing Wang, Xu Wang, Zhiying Li, Dan Niu, Min Wang, Jinzhu Xiang, Yongli Yue, Yajuan Xia, Xueling Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2021/6642983 |
Similar Items
-
miR-375 Inhibits Proliferation of Mouse Pancreatic Progenitor Cells by Targeting YAP1
by: Zhen-Wu Zhang, et al.
Published: (2013-12-01) -
miR-375 and miR-30d in the Effect of Chromium-Containing Chinese Medicine Moderating Glucose Metabolism
by: Qian Zhang, et al.
Published: (2014-01-01) -
Circulating miR-92b and miR-375 for monitoring the chemoresistance and prognosis of small cell lung cancer
by: Ming Li, et al.
Published: (2020-07-01) -
Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development.
by: Wigard P Kloosterman, et al.
Published: (2007-08-01) -
MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma
by: Yin-Ping Fan, et al.
Published: (2017-06-01)